These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24202614)

  • 1. Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases.
    Theibich A; Dreyer L; Magyari M; Locht H
    Clin Rheumatol; 2014 May; 33(5):719-23. PubMed ID: 24202614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term safety of etanercept in elderly subjects with rheumatic diseases.
    Fleischmann R; Baumgartner SW; Weisman MH; Liu T; White B; Peloso P
    Ann Rheum Dis; 2006 Mar; 65(3):379-84. PubMed ID: 16150792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab-induced central nervous system demyelination in a patient with rheumatoid arthritis.
    Shirah B; Altwirgi S; Faridoon I; Alghamdi S
    Neuroradiol J; 2024 Apr; 37(2):234-236. PubMed ID: 37125695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS Demyelination with TNF-α Blockers.
    Kemanetzoglou E; Andreadou E
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):36. PubMed ID: 28337644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events of biological agents in pediatric rheumatologic diseases.
    Polat MC; Mertek S; Özçakar ZB; Çelikel E; Aydın F; Tekin ZE; Elhan AH; Çelikel Acar B; Çakar N
    Postgrad Med; 2024 Mar; 136(2):198-207. PubMed ID: 38415679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Anti-Tumor Necrosis Factor Therapy on The Plasma Atherogenic Index in Rheumatic Diseases.
    Cure O; Kizilkaya B; Ciftel S; Mercantepe F
    Metab Syndr Relat Disord; 2024 May; 22(4):269-275. PubMed ID: 38252497
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of tumor necrosis factor inhibitors on rheumatoid arthritis-induced peripheral neuropathy: A cohort study.
    Wang N; Guo Y; Yang L; Fu W; Xu Y; Hou L; Zhao S; Zhang N
    Neural Regen Res; 2012 Apr; 7(11):862-6. PubMed ID: 25737715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical keratitis and dermatitis following adalimumab treatment.
    Ghali N; Khan AO
    J AAPOS; 2024 Jul; ():103970. PubMed ID: 39002940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.
    Kaltsonoudis E; Zikou AK; Voulgari PV; Konitsiotis S; Argyropoulou MI; Drosos AA
    Arthritis Res Ther; 2014 Jun; 16(3):R125. PubMed ID: 24938855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
    Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
    Tarkiainen M; Tynjälä P; Vähäsalo P; Lahdenne P
    Rheumatology (Oxford); 2015 Jul; 54(7):1170-6. PubMed ID: 25504896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease and demyelination: more than just a coincidence?
    Katsanos AH; Katsanos KH
    Expert Rev Clin Immunol; 2014 Mar; 10(3):363-73. PubMed ID: 24490959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
    Zhu TH; Nakamura M; Abrouk M; Farahnik B; Koo J; Bhutani T
    J Dermatolog Treat; 2016 Oct; 27(5):406-13. PubMed ID: 26837667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of TNF-α blocker immunogenicity in psoriatic arthritis.
    Zisapel M; Zisman D; Madar-Balakirski N; Arad U; Padova H; Matz H; Maman-Sarvagyl H; Kaufman I; Paran D; Feld J; Litinsky I; Wigler I; Caspi D; Elkayam O
    J Rheumatol; 2015 Jan; 42(1):73-8. PubMed ID: 25399390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in psoriatic patients treated with anti-TNF-α therapy.
    Bardazzi F; Odorici G; Virdi A; Antonucci VA; Tengattini V; Patrizi A; Balestri R
    J Dtsch Dermatol Ges; 2014 May; 12(5):401-6. PubMed ID: 24797746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
    Lieberman MR; Liebman TN; Alapati U; Khachemoune A
    Dermatol Online J; 2014 Dec; 21(2):. PubMed ID: 25756476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining biologics with methotrexate in psoriasis: a systematic review.
    van Bezooijen JS; Prens EP; Pradeepti MS; Atiqi R; Schreurs MWJ; Koch BCP; van Gelder T; van Doorn MBA
    Br J Dermatol; 2015 Jun; 172(6):1676-1680. PubMed ID: 25470815
    [No Abstract]   [Full Text] [Related]  

  • 19. Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.
    Vogelzang EH; Pouw MF; Nurmohamed M; Kneepkens EL; Rispens T; Wolbink GJ; Krieckaert CL
    Ann Rheum Dis; 2015 Feb; 74(2):474-5. PubMed ID: 25433018
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of adalimumab and methotrexate combination therapy on generalized pustular psoriasis patients unresponsive to infliximab monotherapy due to anti-infliximab antibody development.
    Kawakami H; Maeda T; Abe N; Matsumoto Y; Mitsuhashi Y; Tsuboi R; Okubo Y
    J Dermatol; 2015 Jan; 42(1):94-5. PubMed ID: 25425479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.